Trial Profile
A retrospective study evaluating renal protection after switching from multiple daily insulin injections to combination use of liraglutide and basal insulin in patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Jul 2017
Price :
$35
*
At a glance
- Drugs Insulin (Primary) ; Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 17 Jul 2017 New trial record
- 13 Jun 2017 Results presented at the 77th Annual Scientific Sessions of the American Diabetes Association